RT Journal Article
SR Electronic
T1 ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF OF TRACHEAL TUBE ISOLATES FROM PATIENTS OF VENTILATOR ASSOCIATED PNEUMONIA (VAP) ADMITTED TO THE ICU OF A TERTIARY CARE HOSPITAL IN RAWALPINDI PAKISTAN
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.12.23288476
DO 10.1101/2023.04.12.23288476
A1 Baba, Miriam Farooq
A1 Abdullah, Ramal
A1 Iqbal, Soman Nadim
A1 Tariq, Maryam
A1 Ali, Muhammad Moaaz
A1 Hassan, Mohammad
A1 Kaleem, Fatima
A1 Abbasi, Shahid Ahmed
YR 2023
UL http://medrxiv.org/content/early/2023/04/17/2023.04.12.23288476.abstract
AB The respiratory system is a complex interconnected functionality which consists of a series of branching tubules and the lungs containing many alveoli. The alveoli are highly vascularized to provide a large surface area for gaseous exchange. The investigation was conducted in the Fauji Foundation Hospital’s Department of Microbiology from November 2019 to June 2022.. The various bacterial strains that were recovered from a total of 802 mechanically intubated individuals make up the data presented in this study. Acinetobacter spp 270 (34%), Pseudomons spp 165(21%), and Klebsiella spp 95 (12%) were the most frequently isolated bacteria. Main Gram-positive organisms isolated included Methicillin-Resistant Staphylococcus aureus 66 (8%), Enterococcus 48 (6%). MRSA was 100% sensitive to Vancomycin, but only 97% sensitive to the Linezolid. The Acinetobacter spp found in the tracheal tubes was reported to be 77% sensitive to Polymyxin B.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This observational study was conducted at the Fauji Foundation Hospital in Rawalpindi's Department of Microbiology from November 2019 to December 2022. The hospital's ethical review committee provided their ethical approval.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors